0 CHECKOUT

PRODUCT FILTERS

CATEGORIES

  • 22
  • 11
  • 8
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1

PRICE

18
21
38
51

PUBLISHED

0
2
3
51

PRODUCT TYPE

44
6
1

Search for: "Nutri Pharma ASA"

51 Products

Nutri Pharma ASA (NUT) - Financial and Strategic Analysis Review

Nutri Pharma ASA (Nutri Pharma ) is a Norway-based biotechnology company. The company is engaged in the treatment and prevention of lifestyle-related diseases. The company's expertise in soy technology...

Published:  September 2010
Price:  From

Nutri Pharma ASA - Company PicShot - Company PicShot

This Company PicShot is a brief, yet detailed, profile of the chosen company. The PicShot profiles the company in terms of historical background, company overview, business segment analysis, a view...

Published:  November 2010
Price:  From

Bionor Pharma ASA - Product Pipeline Review - 2013

Bionor Pharma ASA – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Bionor Pharma ASA - Product Pipeline Review - 2013” provides data on the Bionor Pharma ASA’s...

Published:  April 2013
Price:  From

Bionor Pharma ASA - Product Pipeline Review - 2012

Bionor Pharma ASA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Bionor Pharma ASA - Product Pipeline Review - 2012” provides data on the Bionor Pharma ASA’s...

Published:  September 2012
Price:  From

Bionor Pharma ASA (BIONOR) - Financial and Strategic SWOT Analysis Review

Bionor Pharma ASA (BIONOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by...

Published:  May 2015
Price:  From

Cervical Cancer - Pipeline Review, H2 2013

Cervical Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  August 2013
Price:  From

Hepatitis C - Pipeline Review, H2 2013

Hepatitis C - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  August 2013
Price:  From

Herpes Infections - Pipeline Review, H2 2012

Herpes Infections – Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Herpes Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline This report...

Published:  December 2012
Price:  From

Uterine Cancer - Pipeline Review, H1 2013

Uterine Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Uterine Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  April 2013
Price:  From

Gynecological Cancer - Pipeline Review, H1 2013

Gynecological Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gynecological Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  May 2013
Price:  From

HIV-1 Infection - Pipeline Review, H2 2013

HIV-1 Infection - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'HIV-1 Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  August 2013
Price:  From

Cervical Cancer - Pipeline Review, H1 2013

Cervical Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  February 2013
Price:  From

Influenza - Pipeline Review, H2 2013

Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  August 2013
Price:  From

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

Published:  July 2013
Price:  From

Hepatitis C - Pipeline Review, H1 2013

Hepatitis C – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  February 2013
Price:  From

NeuroSearch A/S

A textual analysis of the financial results for NeuroSearch A/S compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

Published:  August 2015
Price:  From

Aquila

A textual analysis of the financial results for Aquila compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and...

Published:  July 2015
Price:  From

Seasonal Influenza - Pipeline Review, H2 2013

Seasonal Influenza - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Seasonal Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

Published:  July 2013
Price:  From

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2013

Cytomegalovirus (HHV-5) Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

Published:  February 2013
Price:  From

HIV-1 Infection – Pipeline Review, H1 2013

Global Markets Direct’s, 'HIV-1 Infection - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for...

Published:  February 2013
Price:  From
Loading Indicator

Our Clients

  • Carrefour S.A.
  • Dow Chemical Co Ltd.
  • Motorola Solutions, Inc.
  • Pfizer, Inc.
  • Activision Publishing, Inc.
  • 3M Company
  • Estée Lauder Companies Inc.